Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

HMB for Denutrition in Patients With Cirrhosis (HEPATIC)

Authors not listed

Instituto Aragones de Ciencias de la Salud · 2017

Abstract

Cirrhosis is a late stage of hepatic fibrosis caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. The World Health Organization (WHO) has reported that this condition accounts for 1.8% of all deaths in Europe (170,000 deaths/year). Patients with cirrhosis are characterized by severe metabolic alterations, which converge in a malnutritional state. Malnutrition encompasses glucose intolerance, chronic inflammation, altered gut microbiota, reduced muscle mass (sarcopenia), as well as loss and dysregulation of adipose tissue (adipopenia). Malnutrition is the most frequent complication that adversely affects the outcomes of cirrhotic patients. Yet, despite its clinical repercussions and potential reversibility, there are no effective therapies because our limited understanding of the mechanisms underlying this altered metabolism. β-hydroxy β-methylbutyrate (HMB) is a naturally produced substance regarded as safe and effective in preventing muscle loss during chronic diseases. Previous studies have indicated some beneficial effects of HMB itself or its parent metabolite, leucine, on adipose tissue, glucose intolerance, inflammation, and gut microbiota. This study aims to translate those beneficial effects to cirrhotic patients. The investigators hypothesize that HMB can improve cirrhosis-related metabolic abnormalities through its pleiotropic effects. The goals of this study are: i) to perform a randomized clinical trial to evaluate the efficacy of HMB, administered as nutritional supplementation, on clinical symptoms of cirrhosis. ii) to uncover the precise metabolic pathways that underlie HMB action, with a special focus on muscle, adipose tissue, and gut microbiota.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-18 MST

Cite this

APA
Anonymous. (2017). HMB for Denutrition in Patients With Cirrhosis (HEPATIC). <em>Instituto Aragones de Ciencias de la Salud</em>. https://clinicaltrials.gov/study/NCT03285217
Vancouver
Anonymous. HMB for Denutrition in Patients With Cirrhosis (HEPATIC). Instituto Aragones de Ciencias de la Salud. 2017.
BibTeX
@misc{anon2017HMBfor, title = {HMB for Denutrition in Patients With Cirrhosis (HEPATIC)}, author = {Anonymous}, journal = {Instituto Aragones de Ciencias de la Salud}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings